Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6GSK

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

AMPRENAVIR

Brand Name : AGENERASE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 1999-04-15

Application Number : 21007

Regulatory Info : DISCN

Registration Country : USA

blank

02

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

AMPRENAVIR

Brand Name : AGENERASE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date : 1999-04-15

Application Number : 21007

Regulatory Info : DISCN

Registration Country : USA

blank

03

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

AMPRENAVIR

Brand Name : AGENERASE

Dosage Form : SOLUTION;ORAL

Dosage Strength : 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1999-04-15

Application Number : 21039

Regulatory Info : DISCN

Registration Country : USA

blank

04

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Amprenavir

Brand Name : Agenerase

Dosage Form : Oral Solution

Dosage Strength : 15mg/ml

Packaging :

Approval Date : 20/10/2000

Application Number : 20001020000135

Regulatory Info : Deregistered

Registration Country : Sweden

blank

05

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Amprenavir

Brand Name : Agenerase

Dosage Form : Capsule

Dosage Strength : 150mg

Packaging :

Approval Date : 20/10/2000

Application Number : 20001020000128

Regulatory Info : Deregistered

Registration Country : Sweden

blank

06

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

Amprenavir

Brand Name : Agenerase

Dosage Form : Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 20/10/2000

Application Number : 20001020000111

Regulatory Info : Deregistered

Registration Country : Sweden

blank